Patents by Inventor Marja Jaattela

Marja Jaattela has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF SIRAMESINE IN THE TREATMENT OF CANCER
    Publication number: 20090203721
    Abstract: The present invention relates to the treatment of cancer. In particular, the invention provides pharmaceutical compositions comprising siramesine for the treatment of cancer. The invention further provides a method of treatment comprising administering siramesine to a patient suffering from cancer.
    Type: Application
    Filed: April 20, 2009
    Publication date: August 13, 2009
    Applicant: H. Lundbeck A/S
    Inventors: Christian Thomsen, Marcel Leist, Marja Jaattela, Marie Stampe Ostenfeld
  • Use of siramesine in the treatment of cancer
    Publication number: 20060178389
    Abstract: The present invention relates to the treatment of cancer. In particular, the invention provides pharmaceutical compositions comprising siramesine for the treatment of cancer. The invention further provides a method of treatment comprising administering siramesine to a patient suffering from cancer.
    Type: Application
    Filed: December 21, 2005
    Publication date: August 10, 2006
    Inventors: Christian Thomsen, Marcel Leist, Marja Jaattela, Marie Ostenfeld
  • Treatment of diseases characterized by excessive or insufficient cell death
    Publication number: 20040077634
    Abstract: The invention relates to the use of a compound that modulates the association of caspase-9 to Apaf-1 for the treatment of diseases characterized by excessive or insufficient cell death.
    Type: Application
    Filed: September 12, 2003
    Publication date: April 22, 2004
    Inventors: Ulrik Lademann, Marja Jaattela, Dan Peters, Lars Christian B. Ronn